DLBS 1033: Clinical Trials

15 trials of DLBS 1033, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 4 terminated, 2 not yet recruiting, 1 unknown. 9 Phase 2, 8 Phase 3, 2 Not applicable, 2 Phase 4, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 29Completed 3, Terminated 3, Not yet recruiting 1, Unknown 1, Withdrawn 1
Phase 38Terminated 4, Completed 1, Not yet recruiting 1, Unknown 1, Withdrawn 1
Not applicable2Completed 1, Not yet recruiting 1
Phase 42Completed 2
Phase 11Completed 1

Follow DLBS 1033: new trials by email Literature Review of DLBS 1033 trials Research Report on DLBS 1033

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
DLBS1033 as Adjunctive Therapy for Patients With Diabetic Neuropathy
DLBS1033, Placebo - Diabetic Neuropathy
Not applicableNot yet recruitingRS H Adam Malik802026-08-012026-07-06
The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy
DLBS1033, Placebo Comparator: Placebo + Standard Therapy - Diabetic Polyneuropathy, Peripheral Nervous System Diseases
Phase 2 / Phase 3Not yet recruitingUniversitas Sebelas Maret342026-03-012026-03-16
Effects of Lumbrokinase DLBS1033 on D-Dimer, Interleukin-6, and Clinical Outcomes in Patients With Pneumonia and Sepsis
Placebo Tablet(s), DLBS1033 - Pneumonia, Sepsis
Phase 2CompletedUniversitas Sebelas Maret502025-08-142026-10-23
Comparing Oral Lumbrokinase DLBS1033 and Betahistine Mesylate in Benign Paroxysmal Positional Vertigo
DLBS1033, Betahistine Mesylate tablet - Benign Paroxysmal Positional Vertigo (Disorder)
Phase 4CompletedUniversitas Sebelas Maret442024-04-012025-07-20
The Benefit of Add On DLBS1033 for Ischemic Stroke Patient
DLBS1033, Aspirin, Statin - Ischemic Stroke
Phase 2 / Phase 3UnknownDuta Wacana Christian University1802020-04-012020-06-11
Effect of DLBS1033 After Primary PCI in Patients With STE-ACS
DLBS1033, Placebo, Standard therapy - ST Elevation Myocardial Infarction
Phase 2 / Phase 3TerminatedDexa Medica Group232016-11-012023-09-08
DLBS1033 for Acute NSTEMI Without Early Coronary Revascularization
DLBS1033, Placebo - Acute Non-ST Elevation Myocardial Infarction
Phase 2 / Phase 3WithdrawnDexa Medica Group2015-11-012016-04-20
DLBS1033 Treatment in Diabetic With Peripheral Arterial Disease
DLBS1033, Placebo - Diabetes, Peripheral Arterial Disease
Phase 2 / Phase 3TerminatedDexa Medica Group112015-06-032018-07-26
DLBS1033 for Acute Ischemic Stroke Patients
DLBS1033, Placebo - Acute Ischemic Stroke, Partial Anterior Circulation Infarct
Phase 2 / Phase 3TerminatedDexa Medica Group802014-11-112023-12-12
DLBS1033 for the Treatment of Acute Ischemic Stroke
Placebo, DLBS1033 - Acute Ischemic Stroke
Phase 3TerminatedDexa Medica Group92014-10-012017-05-04
Biological Half Life of DLBS1033 in Healthy Volunteers
DLBS1033 - Healthy Condition
Phase 1 / Phase 2CompletedUniversitas Indonesia142013-06-012017-05-12
Efficacy and Safety of DLBS1033 in Subjects With Type 2 Diabetes Mellitus
DLBS1033, placebo tablet of DLBS1033 - Type 2 Diabetes Mellitus
Phase 4CompletedDexa Medica Group1222013-05-012016-08-04
The Effects of DLBS1033 on Haemostasis Parameters in Healthy Volunteers
DLBS1033, placebo - Healthy
Phase 2CompletedUniversitas Indonesia212012-07-012017-05-15
Efficacy of DLBS1033 in Patients With Acute Ischemic Stroke
DLBS1033, Aspirin, Clopidogrel - Acute Ischemic Stroke
Phase 3CompletedDexa Medica Group1262012-05-012014-06-04
Safety and Efficacy of DLBS1033 in Healthy Subjects
DLBS1033, Placebo - Healthy
Not applicableCompletedDexa Medica Group202011-05-012012-08-23

Conditions studied

Ischemic Stroke (4)  ·  Diabetes Mellitus (2)  ·  Diabetic Neuropathies (2)  ·  Thrombophilia (2)  ·  Acute Coronary Syndrome (1)  ·  Benign Paroxysmal Positional Vertigo (1)  ·  Blood Coagulation Disorders (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Dizziness (1)  ·  Hereditary Sensory and Autonomic Neuropathies (1)  ·  Inflammation (1)  ·  Non-ST Elevated Myocardial Infarction (1)  ·  Peripheral Arterial Disease (1)  ·  Peripheral Nervous System Diseases (1)  ·  Pneumonia (1)

Sponsors

Dexa Medica Group (8)  ·  Universitas Sebelas Maret (3)  ·  Universitas Indonesia (2)  ·  Duta Wacana Christian University (1)  ·  RS H Adam Malik (1)

Countries

Indonesia (15)

Top investigators

Muhammad Munawar, SpJP(K), MD (2)  ·  Anggi Gayatri, MD, SpFK (1)  ·  Asman Manaf, Prof. Dr. dr., SpPD-KEMD (1)  ·  Danang A Yunaidi, Dr (1)  ·  Diah H Soeryaningtias, Sp.S, MD (1)  ·  Dian Cahyani, Sp.S, MD (1)  ·  Dodik Tugasworo, Sp.S(K), MD (1)  ·  Eldaa Putik Bunga Melati, MD (1)  ·  Gotot S PW, Sp.S, MD (1)  ·  Hanindia R. Prabaningtyas, Sp.S(K), MD (1)  ·  Ika Y Margaretha, Sp.S, MD (1)  ·  Ismail Setyopranoto, dr., SpS(K) (1)  ·  Ismi Purnawan, SpJP(K), MD (1)  ·  Ketut Suastika, Prof, SpPD, MD (1)  ·  Krisandi Hartanto, MD (1)

Results publications

PMID 11321442, PMID 17489364, PMID 21403877, PMID 9875462